ABL1 and in situ carcinoma: When endogenous BCR-ABL was inhibited by tyrosine kinase inhibitors in BCR-ABL positive ALL long-term cultured cells and in K562 cells, CIS and SOCS1-3 showed comparable down-regulation of gene and protein expression (Fig 1).